Semaglutide vs Naltrexone for Binge Eating: Which Medication Actually Works?

Sarah had been struggling with binge eating episodes three to four times a week for years. She'd tried therapy, self-help programs, and even a brief stint with an SSRI that her psychiatrist recommended. Nothing seemed to quiet the intense urges that led to eating thousands of calories in a single sitting, followed by crushing guilt and shame. When her doctor mentioned that two medications—semaglutide and naltrexone—were showing promise for binge eating disorder, she had the same question most patients ask: which one actually works?

It's a fair question, especially since neither medication is FDA-approved specifically for binge eating disorder. Yet both are being prescribed off-label with increasing frequency, and for good reason. They just work in completely different ways, target different mechanisms in the brain and body, and tend to help different types of patients. Let's break down what the research actually shows.

How Semaglutide Addresses Binge Eating

Semaglutide belongs to a class of medications called GLP-1 receptor agonists, originally developed for type 2 diabetes and later approved for weight management. But what we've learned in clinical practice is that its effects go far beyond blood sugar control. The medication works on multiple levels that directly impact binge eating behavior.

First, semaglutide slows gastric emptying. Your stomach literally takes longer to empty its contents into your small intestine. For someone prone to binge eating, this creates a persistent feeling of fullness that makes it physically uncomfortable to consume large quantities of food in one sitting. We see this frequently in our patients—they describe hitting a wall of satiety much earlier than before.

Second, and perhaps more importantly for binge eating, semaglutide acts on areas of the brain involved in appetite regulation and reward processing. It works on the hypothalamus to reduce hunger signals, but it also appears to dampen the reward response to highly palatable foods. That intense drive to eat an entire sleeve of cookies? Many patients report it simply... fades.

The research backing this up is compelling. While the major trials like STEP 1 focused primarily on weight loss, the secondary analyses revealed significant reductions in food cravings and loss of control eating. In STEP 1, participants taking semaglutide 2.4mg lost an average of 14.9% of their body weight over 68 weeks, but they also reported substantial decreases in appetite and preoccupation with food.

More specific to binge eating, smaller studies have shown real promise. A 2023 pilot study published in Obesity followed patients with binge eating disorder who received semaglutide for 16 weeks. The results showed a 61% reduction in binge eating episodes, with many participants achieving complete remission of their binge eating behavior. These weren't just minor improvements—patients described a fundamental shift in their relationship with food.

The typical dosing for binge eating follows the weight management protocol: starting at 0.25mg weekly and gradually increasing to 2.4mg over several months. This slow titration helps minimize side effects, which we'll get to shortly.

How Naltrexone Targets Binge Eating

Naltrexone takes an entirely different approach. Originally approved for alcohol and opioid dependence, it works by blocking opioid receptors in your brain. You might wonder what opioids have to do with eating—the connection isn't obvious at first.

Here's the thing: when you eat highly palatable foods (think sugar, fat, salt in perfect combination), your brain releases endogenous opioids along with dopamine. These are your body's natural feel-good chemicals. For people with binge eating disorder, this reward system often functions differently—either more intensely or in a way that drives compulsive eating behavior despite negative consequences.

By blocking opioid receptors, naltrexone essentially dampens the pleasure and reward you get from eating. This doesn't make food taste bad or eliminate normal hunger. What it does is reduce the hedonic drive—that intense psychological urge to eat for pleasure or emotional relief rather than physical hunger.

The evidence for naltrexone in binge eating is mixed but noteworthy. A 2016 study in the Journal of Clinical Psychiatry found that naltrexone 50mg daily reduced binge eating episodes by about 30% compared to placebo. Not as dramatic as the semaglutide numbers, but still clinically meaningful for many patients.

Where naltrexone really gets interesting is in combination therapy. The naltrexone-bupropion combination (marketed as Contrave for weight loss) has shown stronger effects than naltrexone alone. The bupropion component appears to enhance naltrexone's effects on the reward system. Studies of this combination have shown reductions in binge eating frequency of 40-50% in some patients.

Dosing typically starts at 25mg daily, increasing to 50mg after a week. Some clinicians use higher doses (up to 100mg daily) for patients who don't respond adequately to 50mg. The combination products follow different titration schedules.

One advantage naltrexone has: it's been around longer and is available as an inexpensive generic. A month's supply often costs less than $30 without insurance, making it more accessible than semaglutide for patients without coverage or those who don't qualify for patient assistance programs.

Comparing Effectiveness and Side Effects

When patients ask which medication works better, the honest answer is: it depends on what's driving your binge eating and what side effects you're willing to tolerate.

Semaglutide appears to produce larger reductions in binge eating frequency in the limited head-to-head data we have. That 61% reduction in episodes is hard to ignore. But semaglutide also comes with a predictable constellation of gastrointestinal side effects. Nausea affects about 44% of people starting the medication, though it typically improves after the first month. Diarrhea, constipation, and abdominal discomfort are also common, especially during dose escalations.

For some patients, these GI effects actually contribute to the anti-binge effect—you simply don't want to eat large quantities when you're nauseated. But that's not a sustainable or healthy way to manage binge eating long-term. The goal is for the nausea to subside while the appetite-regulating effects persist.

Naltrexone's side effect profile is different. The most common complaints are nausea (less severe than with semaglutide for most people), headache, dizziness, and fatigue. Some people report feeling emotionally blunted or experiencing less pleasure from activities beyond eating. This makes sense given how the medication works, but it can be concerning if you're already dealing with depression.

There's also a significant consideration with naltrexone: you cannot take it if you're using opioid pain medications. It will block their effects and can even precipitate withdrawal if you have opioids in your system. This eliminates naltrexone as an option for people managing chronic pain with opioids.

The weight loss component differs substantially between the two. Semaglutide produces significant weight loss in most patients—that 15% average from STEP 1, with some people losing considerably more. Naltrexone alone produces modest weight loss, typically 5-7 pounds over several months. The combination naltrexone-bupropion performs better, with average weight loss around 5-10% of body weight.

For people with binge eating disorder who are also dealing with obesity (which describes about 30% of people with BED), semaglutide's robust weight loss effects can feel like addressing two problems at once. But for people at normal weight or only slightly overweight, significant weight loss might not be desirable or healthy.

Which Patients Respond Better to Each Medication

In our clinical experience, certain patient profiles tend to respond better to one medication over the other. This isn't about following rigid rules—everyone's different—but patterns do emerge.

Semaglutide tends to work particularly well for patients whose binge eating is driven by physical hunger and constant food thoughts. If you find yourself preoccupied with food throughout the day, planning your next meal while eating the current one, or experiencing intense physical hunger that leads to loss of control eating, semaglutide's effects on appetite and satiety can be transformative.

It's also a strong option for people with metabolic syndrome, prediabetes, or type 2 diabetes in addition to binge eating disorder. You're addressing multiple health concerns with one medication. The cardiovascular benefits demonstrated in the SELECT trial (20% reduction in major adverse cardiovascular events) add another layer of benefit for patients with heart disease risk factors.

Naltrexone often works better for people whose binge eating is more about the reward-seeking behavior than physical hunger. If your binges are triggered by stress, emotions, or the simple pleasure of eating, and you don't necessarily feel physically hungry before a binge, blocking that reward pathway might be more effective. Think of it as turning down the volume on food as a coping mechanism.

Patients with a history of other addictive or compulsive behaviors sometimes respond particularly well to naltrexone. There seems to be overlap in how the brain processes different types of reward-seeking behavior. Some people also prefer naltrexone because it's a daily pill rather than a weekly injection, and there's no need for dose titration over months.

From the Ozari Care Team

We often see patients who've tried one medication without success and assume medication won't help them, when really they just needed a different approach. If you tried naltrexone and didn't see meaningful improvement, that doesn't predict how you'll respond to semaglutide—they're working on completely different systems. What we tell patients is that medication should be combined with addressing the psychological and behavioral aspects of binge eating for the best outcomes. Neither semaglutide nor naltrexone is a magic bullet, but for the right patient, they can be the tool that finally makes other interventions like therapy actually stick.

Key Takeaways

• Semaglutide reduces binge eating episodes by an average of 61% in research studies, primarily through reducing appetite and slowing stomach emptying, while naltrexone reduces episodes by about 30% by dampening the reward response to food
• Semaglutide produces significant weight loss (average 15% of body weight) along with reduced binge eating, while naltrexone alone causes minimal weight loss but may work better for reward-driven eating behavior
• The most common side effects are nausea and GI issues with semaglutide versus headache and emotional blunting with naltrexone, and you cannot use naltrexone if you take opioid pain medications
• Patients with constant food thoughts and physical hunger often respond better to semaglutide, while those with stress-triggered or emotion-driven binges may see better results with naltrexone
• Neither medication is FDA-approved specifically for binge eating disorder, but both are commonly prescribed off-label and should be combined with behavioral therapy for best results

Frequently Asked Questions

Can you take semaglutide and naltrexone together for binge eating?

There's no specific contraindication to using both medications simultaneously, and some clinicians do prescribe them in combination for patients who've had partial responses to either medication alone. The theory is that you'd be addressing both the appetite/satiety mechanisms (with semaglutide) and the reward pathways (with naltrexone) at the same time. However, there's limited research on this combination specifically for binge eating disorder, so it's considered more experimental. You'd also be dealing with the side effects of both medications, which could be challenging during the initial weeks.

How long does it take for each medication to reduce binge eating episodes?

With semaglutide, many patients notice reduced appetite and fewer food cravings within the first 2-4 weeks, but the full effect on binge eating behavior typically emerges over 8-12 weeks as you reach higher doses. The medication requires gradual dose escalation over several months to reach the therapeutic 2.4mg dose. Naltrexone works faster in some ways—because there's minimal dose escalation required, you're at the therapeutic dose within a week or two. Some patients report reduced binge urges within days, while others need 4-6 weeks to notice meaningful changes. If you haven't seen any improvement after 8-12 weeks on either medication at therapeutic doses, it's worth discussing alternative approaches with your provider.

Will insurance cover semaglutide or naltrexone for binge eating disorder?

This is frustratingly complicated. Since neither medication is FDA-approved for binge eating disorder, coverage depends on how your provider codes the prescription and your specific insurance plan. Naltrexone is inexpensive as a generic, so even if insurance doesn't cover it for this indication, it's usually affordable out of pocket. Semaglutide is a different story—brand-name Ozempic and Wegovy can cost over $1,000 monthly without coverage. Some insurance plans will cover semaglutide if you have type 2 diabetes or meet specific BMI criteria for weight management, even if the real goal is treating binge eating. You'll likely need prior authorization and possibly documentation of failed attempts with other treatments. Compounded semaglutide, like what we offer at Ozari, provides a more affordable option for patients who don't have insurance coverage.

Do you gain the weight back if you stop taking semaglutide for binge eating?

This is one of the most common concerns patients raise, and it's a legitimate one. Research shows that when people stop semaglutide, appetite and hunger signals typically return toward baseline within weeks, and many people do regain weight. A follow-up to the STEP 1 trial found that participants regained about two-thirds of their lost weight within a year of stopping the medication. However, the picture is more complex for binge eating specifically. Some patients find that the period on semaglutide gave them time to develop new eating patterns and coping strategies that persist even after stopping. Others find their binge eating returns and need to either resume semaglutide or transition to a different treatment approach. There's growing recognition that for some people, this may need to be a long-term medication rather than a temporary intervention.

Can naltrexone make depression worse when treating binge eating?

This is a valid concern since naltrexone blocks opioid receptors that are part of your brain's reward and pleasure systems. Some people do report feeling emotionally flat or experiencing anhedonia (reduced ability to feel pleasure) on naltrexone, which could theoretically worsen depression symptoms. However, research specifically examining this hasn't shown increased depression rates in people taking naltrexone for various indications. In fact, some patients with binge eating disorder report improved mood because they're no longer dealing with the shame and distress of frequent binge episodes. That said, if you have major depression, it's worth discussing this concern with your provider and monitoring your mood closely when starting naltrexone. The naltrexone-bupropion combination might actually be preferable in this case, since bupropion is an antidepressant that could offset any mood-dulling effects.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, shipped to your door. Learn more at ozarihealth.com.